Prader-Willi syndrome, a rare genetic disorder causing insatiable hunger, has made strides with the FDA's approval of Vykat XR, offering hope and relief to patients like Dean Shenk, whose life has been transformed by the drug. Despite challenges, research into rare genetic obesity and other treatment options is pushing forward, bringing hope to patients and families affected by this condition.